...
首页> 外文期刊>Experimental and clinical psychopharmacology >Effects of GluN2B-selective Antagonists on Delay and Probability Discounting in Male Rats: Modulation by Delay/Probability Presentation Order
【24h】

Effects of GluN2B-selective Antagonists on Delay and Probability Discounting in Male Rats: Modulation by Delay/Probability Presentation Order

机译:GLUN2B选择性拮抗剂对雄性大鼠延迟和概率折扣的影响:延迟/概率呈现顺序调制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The contribution of the GluN2B subunit of the NMDA receptor to impulsivity has recently been examined. Ro 63-1908, a highly selective antagonist for the GluN2B, decreases impulsive choice. Because the order in which delays are presented modulates drug effects in discounting procedures, one goal of the current study was to determine the effects of Ro 63-1908 in delay discounting procedures in which the delays to obtaining the large reinforcer either increase or decrease across the session. We also determined if Ro 63-1908 differentially alters risky choice in probability discounting procedures that use ascending/descending schedules. Male rats were trained in either delay (n = 24) or probability (n = 24) discounting in which the delay to/odds against reinforcement were presented in either ascending or descending order (n = 12 each schedule). Following training, rats received the GluN2B antagonists Ro 63-1908 (0-1.0 mg/kg) and CP-101,606 (0-3.0 mg/kg). In delay discounting, Ro 63-1908 (1.0 mg/kg), but not CP-101,606, decreased choice for the large reinforcer, but only when the delays decreased across the session. In probability discounting, Ro 63-1908 (0.3 mg/kg)/CP-101,606 (1.0 mg/kg) increased choice for the large reinforcer when the probability of obtaining this alternative decreased across the session, but Ro 63-1908 (1.0 mg/kg)/CP-101,606 (3.0 mg/kg) decreased choice when the probabilities increased. These results show that the GluN2B is a mediator of impulsive/risky choice, but the effects of GluN2B antagonists are dependent on the order in which delays/probabilities are presented.
机译:最近研究了NMDA受体的GLU2B亚基的贡献。 RO 63-1908是GLUN2B的高度选择性拮抗剂,降低了冲动的选择。由于延迟呈现延迟的顺序调制折扣程序中的药物影响,目前研究的一个目标是确定RO 63-1908在延迟贴现程序中的影响,其中获得大型加强件的延迟增加或减少会议。我们还确定了如果RO 63-1908在使用升序/下降时间表的概率折扣程序中差别改变风险选择。雄性大鼠在延迟(n = 24)或概率(n = 24)折扣中训练,其中以升序或降序呈现对抗屈服的延迟/赔率(n = 12个时间表)。培训后,大鼠接受GLUN2B拮抗剂RO 63-1908(0-1.0mg / kg)和CP-101,606(0-3.0mg / kg)。延迟折扣,RO 63-1908(1.0 mg / kg),但不是CP-101,606,对大型加强杆菌的选择减少,但只有在会议上减少时才会减少。在概率折扣时,RO 63-1908(0.3 mg / kg)/ cp-101,606(1.0 mg / kg)当在会议上获得这种替代方案的可能性时,大加强杆菌的选择增加,但ro 63-1908(1.0 mg / kg)/ cp-101,606(3.0 mg / kg)在概率增加时的选择减少。这些结果表明,GLUN2B是一种冲动/危险选择的介质,但GLUN2B拮抗剂的效果取决于延迟/概率的呈现顺序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号